Plant Health Care – executive interview

Plant Health Care – executive interview

In this video, Dr Chris Richards, Plant Health Care’s CEO, discusses FY19 performance. He comments on the status of PREtec peptide commercialisation and the impact that the COVID-19 pandemic has had on the business, noting that there has been little impact on production so far, although demand for some crop applications has been affected. He describes how he sees revenues and profitability developing once the lockdowns have eased and concludes with some remarks on the relationship with recent investor, Ospraie Ag Science.

Plant Health Care provides innovative proprietary agricultural biological products to the global agricultural market. These focus on improving crop performance, strengthening a plant’s resistance to soil pests or drought and increasing yield.


You may also be interested in these:

Cookie Policy Overview
Edison Group

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which section of the website you find more interesting and useful. See our Cookie Policy for more information.

Strictly necessary and functional

These cookies are used to deliver our website and content. Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds.

Advertising

Advertising Cookies collect information about your browsing habits such as the pages you visit and links you follow. These audience insights are used to make our website more relevant.

Performance

Performance Cookies collect anonymous information designed to help us improve the site and respond to the needs of our audiences. We use this information to make our site faster, more relevant and improve the navigation for all users.